SUPN

Supernus Pharmaceuticals Inc

Jun 24 • 04:00PM ET

45.14

+0.66 1.48 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: INDV ALKS AMRX KNSA LNTH NBIX ACAD TLX BIIB VRTX

| Held by: IJR VTI VB IWM VBR VXF SPSM IWN IJT VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	6.35%	Shs Outstand	58.04M	Perf Week	3.58%
Market Cap	2.62B	Forward P/E	11.52	EPS next Y	3.92	Insider Trans	-4.69%	Shs Float	54.35M	Perf Month	-6.37%
Enterprise Value	2.28B	PEG	0.62	EPS next Q	0.43	Inst Own	99.67%	Short Float	9.97%	Perf Quarter	-8.59%
Income	-29.02M	P/S	3.37	EPS this Y	-23.13%	Inst Trans	1.09%	Short Ratio	8.59	Perf Half Y	-12.32%
Sales	776.83M	P/B	2.43	EPS next Y	57.64%	ROA	-2.04%	Short Interest	5.42M	Perf YTD	-9.18%
Book/sh	18.55	P/C	6.82	EPS next 5Y	18.58%	ROE	-2.75%	52W High	59.68 -24.36%	Perf Year	42.53%
Cash/sh	6.62	P/FCF	31.85	EPS past 3/5Y	- -	ROIC	-2.62%	52W Low	30.83 46.42%	Perf 3Y	38.34%
Dividend Est.	-	EV/EBITDA	45.81	Sales past 3/5Y	2.52% 6.68%	Gross Margin	76.89%	Volatility	2.70% 3.18%	Perf 5Y	39.49%
Dividend TTM	-	EV/Sales	2.93	EPS Y/Y TTM	-145.12%	Oper. Margin	-6.13%	ATR (14)	1.51	Perf 10Y	144.79%
Dividend Ex-Date	-	Quick Ratio	1.72	Sales Y/Y TTM	16.29%	Profit Margin	-3.74%	RSI (14)	45.84	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	1.96	EPS Q/Q	81.20%	SMA20	0.68%	Beta	0.55	Target Price	62.83
Payout	-	Debt/Eq	0.04	Sales Q/Q	38.63%	SMA50	-5.39%	Rel Volume	1.21	Prev Close	44.48
Employees	778	LT Debt/Eq	0.03	Earnings	May 05 AMC	SMA200	-7.85%	Avg Volume	630.79K	Price	45.14
IPO	May 01, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	102.29% 7.67%	Trades		Volume	759,697	Change	1.48%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)